Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Haemodialysis Patients
NCT07762807Recruiting
- Sponsor
- King's College London
- Start
- Apr 2025
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of colchicine in myocardial infarction (MI), stroke and arteriovenous fistula (AVF), sponsored by King's College London. Primary endpoint: Feasibility to progress to a full-scale trial at 14 weeks. Started Apr 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
myocardial infarction (MI)strokearteriovenous fistula (AVF)
Beyond the preview
Go deeper on NCT07762807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07762807.